Sebastiaan J. Trietsch, PhD profile page

Chief Technology Officer

at MIMETAS

Bas Trietsch is the CTO and co-founder of MIMETAS. He is a co-inventor of the OrganoPlate®, optimized it towards a mass manufacturable product and enabled the establishment of MIMETAS’ production facility. He developed the initial tissue models on the OrganoPlate® and continues to support assay development in the OrganoPlate®. As CTO, he currently drives the product development of the OrganoPlate® and its peripheral equipment. Bas holds a masters degree and PhD in biopharmaceutical sciences from Leiden University and has co-authored over 30 peer-reviewed publications and patents.

Got a Question for Sebastiaan J. Trietsch, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Published Content

Total: 1

Digital wireframe of a human figure symbolizing data-driven human-relevant models in science.

Industry Insight

Enhancing Drug Screening With Human-Relevant Models

In this interview, Sebastiaan J. Trietsch, Chief Technology Officer at MIMETAS, discusses how microphysiological systems are advancing drug discovery through scalable human-relevant models and AI integration.